Roger E. Susi - Jul 26, 2021 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
President, CEO and Chairman, Director, 10%+ Owner
Signature
/s/ Roger E. Susi
Stock symbol
IRMD
Transactions as of
Jul 26, 2021
Transactions value $
-$345,550
Form type
4
Date filed
7/28/2021, 11:30 AM
Previous filing
Jul 21, 2021
Next filing
Aug 4, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Sale -$173K -5K -0.52% $34.68 951K Jul 26, 2021 By Roger E. Susi Revocable Trust F1, F2, F4
transaction IRMD Common Stock Sale -$172K -5K -0.53% $34.43 946K Jul 27, 2021 By Roger E. Susi Revocable Trust F1, F3, F4
holding IRMD Common Stock 2.36M Jul 26, 2021 By Matthew Susi 2008 Dynasty Trust F4
holding IRMD Common Stock 2.36M Jul 26, 2021 By Phillip Susi 2008 Dynasty Trust F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $34.39 to $35.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $33.66 to $34.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.